New Market Report Now Available: Illumina, Inc. (ILMN) - Product Pipeline Analysis, 2013 Update
Illumina, Inc. (Illumina) is a molecular diagnostics company. It develops, manufactures and markets life science tools and integrated systems for genetic variation and function analysis. The company offers solutions for copy number variation, single nucleotide polymorphism genotyping, gene expression profiling, deoxyribonucleic acid methylation studies and low multiplex analysis of DNA, RNA and protein and small ribonucleic acid. Illumina offers its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations.
View full press release